雷米普利与心血管风险降低 - Suppr | 超能文献

Ramipril and cardiovascular risk reduction.

作者信息

Nichols Wilmer W, Schuler Brian, O'Rourke Michael F

出版信息

Circulation. 2002 Jun 25;105(25):e194-5; author reply e194-5. doi: 10.1161/01.cir.0000018901.71457.10.

DOI:10.1161/01.cir.0000018901.71457.10

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Ramipril and cardiovascular risk reduction.

Circulation. 2002 Jun 25;105(25):e194-5; author reply e194-5. doi: 10.1161/01.cir.0000018901.71457.10.

2

Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?

J Am Coll Cardiol. 2004 Jun 16;43(12):2216-8. doi: 10.1016/j.jacc.2004.03.024.

3

Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

Circulation. 2009 Oct 6;120(14):1380-9. doi: 10.1161/CIRCULATIONAHA.109.865774. Epub 2009 Sep 21.

4

[A decrease in left ventricular hypertrophy and the dynamics of the parameters of circadian BP monitoring under the influence of ramipril in patients with essential arterial hypertension].

Ter Arkh. 1997;69(4):18-20.

5

Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.

Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1359-68.

6

Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.

Diabetes Care. 1998 May;21(5):804-9. doi: 10.2337/diacare.21.5.804.

7

[Remission of left ventricular hypertrophy with ramipril independently of blood pressure changes: the HYCAR study (cardiac hypertrophy and ramipril)].

Arch Mal Coeur Vaiss. 1995 Feb;88 Spec No 2:35-42.

8

Risk reduction for stroke and coronary events.

Lancet. 2002 Apr 6;359(9313):1249; author reply 1250-1. doi: 10.1016/S0140-6736(02)08234-X.

9

Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.

Diabetes Care. 1999 Jan;22(1):178-9. doi: 10.2337/diacare.22.1.178a.

10

Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.

Arch Mal Coeur Vaiss. 1995 Feb;88 Spec No 2:31-4.